A carregar...
Access to new cancer medicines in Australia: dispelling the myths and informing a public debate
Despite the high level of spending on cancer medicines in Australia, consumer organisations and the pharmaceutical industry often make claims of delayed or lack of access to new cancer medicines—claims that are frequently supported by prominent coverage in the Australian media. These claims, while m...
Na minha lista:
| Publicado no: | J Pharm Policy Pract |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4823878/ https://ncbi.nlm.nih.gov/pubmed/27057313 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40545-016-0062-x |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|